Silence Therapeutics Stocks Close at $19.58 on Merck KGaA's $20 Cash Bid
Silence Therapeutics (Nasdaq: SLN) closed at $19.58 on Monday October 19, 2026, up $10.90 or 125.58% from Friday's $8.68, following Merck KGaA's $20.00 per American depositary share cash acquisition offer. The transaction is structured as a UK scheme of arrangement under Part 26 of the Companies
GateMacroTradfiHub·10-20 13:33
